Tom Allen is Director at Syneos Health, Inc. (SYNH). They have made 6 open-market trades across 1 company since 2020, most recently 2021-06-07.
CIK 0001712910
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SYNH | 273,821 | $11.8M |
Shares reported on the most recent Form 4, priced at the 2021-06-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SYNH | SELL | 2021-06-07 | 2021-06-09 | $81.20 | $1.0B | +3.5% | +9.3% | +14.3% |
| SYNH | SELL | 2021-05-14 | 2021-05-18 | $81.04 | $72.8M | +4.0% | +1.1% | +5.3% |
| SYNH | SELL | 2021-05-06 | 2021-05-10 | $81.04 | $649.7M | +6.2% | +2.0% | +3.8% |
| SYNH | SELL | 2021-03-03 | 2021-03-05 | $74.18 | $690.5M | +7.6% | +6.3% | +16.2% |
| SYNH | SELL | 2020-12-03 | 2020-12-07 | $61.28 | $395.7M | +3.3% | +10.7% | +8.9% |
| SYNH | SELL | 2020-09-17 | 2020-09-21 | $59.26 | $446.4M | +4.0% | +7.0% | +28.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.